ANA, anti-dsDNA, phospholipids are included in the 11 criteria to diagnose SLE including the new European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019 classification criteria which has a sensitivity of 96% and a specificity of 93.4% (9). This evidence concerns the gene BTG3 and systemic lupus erythematosus.